CODX – Co-Diagnostics, Inc.
CODX
$0.279Name : Co-Diagnostics, Inc.
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $2,457,989.00
EPSttm : -26.14
Co-Diagnostics, Inc.
$0.279
CODX — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
7.1
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
1.19
EPS Last/This Y
32.15
EPS This/Next Y
2.27
Price
0.29
Target Price
4
Analyst Recom
1
Performance Q
-80.49
Upside
-227,117.2%
Beta
3.21
Ticker: CODX
22 items
«
‹
of 1
›
»
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-10-12 | CODX | 1.25 | N/A | N/A | 0 |
| 2026-10-13 | CODX | 1.07 | N/A | N/A | 0 |
| 2026-10-14 | CODX | 0.7943 | N/A | N/A | 0 |
| 2026-10-15 | CODX | 0.7215 | N/A | N/A | 0 |
| 2026-10-16 | CODX | 0.6533 | N/A | N/A | 0 |
| 2026-10-19 | CODX | 0.6725 | N/A | N/A | 0 |
| 2026-10-20 | CODX | 0.6509 | N/A | N/A | 0 |
| 2026-10-21 | CODX | 0.6345 | N/A | N/A | 0 |
| 2026-10-22 | CODX | 0.5699 | N/A | N/A | 0 |
| 2026-10-23 | CODX | 0.5448 | N/A | N/A | 0 |
| 2026-10-26 | CODX | 0.56 | N/A | N/A | 0 |
| 2026-10-27 | CODX | 0.4698 | N/A | N/A | 0 |
| 2026-10-28 | CODX | 0.4435 | N/A | N/A | 0 |
| 2026-10-29 | CODX | 0.3955 | N/A | N/A | 0 |
| 2026-10-30 | CODX | 0.3694 | N/A | N/A | 0 |
| 2026-11-02 | CODX | 0.3532 | N/A | N/A | 0 |
| 2026-11-03 | CODX | 0.38 | N/A | N/A | 0 |
| 2026-11-04 | CODX | 0.3562 | N/A | N/A | 0 |
| 2026-11-05 | CODX | 0.2719 | N/A | N/A | 0 |
| 2026-11-06 | CODX | 0.2451 | N/A | N/A | 0 |
| 2026-11-09 | CODX | 0.32 | N/A | N/A | 0 |
| 2026-11-10 | CODX | 0.2886 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
22 items
«
‹
Current Page1 of 1
›
»
22 items
«
‹
of 1
›
»
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-10-12 | CODX | 1.25 | 73.2 | - | -3.10 |
| 2026-10-13 | CODX | 1.11 | 73.2 | - | -3.10 |
| 2026-10-14 | CODX | 0.79 | 73.2 | - | -3.10 |
| 2026-10-15 | CODX | 0.72 | 73.2 | - | -3.10 |
| 2026-10-16 | CODX | 0.64 | 73.2 | - | -3.10 |
| 2026-10-19 | CODX | 0.67 | 73.2 | - | -3.10 |
| 2026-10-20 | CODX | 0.67 | 73.2 | - | -3.10 |
| 2026-10-21 | CODX | 0.65 | 73.2 | - | -3.10 |
| 2026-10-22 | CODX | 0.57 | 73.2 | - | -3.10 |
| 2026-10-23 | CODX | 0.55 | 73.2 | - | -3.10 |
| 2026-10-26 | CODX | 0.55 | 73.2 | - | -3.10 |
| 2026-10-27 | CODX | 0.46 | 73.2 | - | -3.10 |
| 2026-10-28 | CODX | 0.44 | 73.2 | - | -3.10 |
| 2026-10-29 | CODX | 0.40 | 73.2 | - | -3.10 |
| 2026-10-30 | CODX | 0.37 | 73.2 | - | -3.10 |
| 2026-11-02 | CODX | 0.36 | 73.2 | - | -3.10 |
| 2026-11-03 | CODX | 0.38 | 73.2 | - | -3.10 |
| 2026-11-04 | CODX | 0.36 | 73.2 | - | -3.10 |
| 2026-11-05 | CODX | 0.27 | 73.2 | - | -3.10 |
| 2026-11-06 | CODX | 0.26 | 73.2 | - | -3.10 |
| 2026-11-09 | CODX | 0.33 | 73.2 | - | -3.10 |
| 2026-11-10 | CODX | 0.29 | 73.2 | - | -3.10 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
22 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-10-12 | CODX | 0.00 | 10.92 | 5.79 |
| 2026-10-13 | CODX | 0.00 | 10.92 | 5.79 |
| 2026-10-14 | CODX | 0.00 | 10.92 | 5.79 |
| 2026-10-15 | CODX | 0.00 | 10.92 | 5.79 |
| 2026-10-16 | CODX | 0.00 | 10.92 | 5.78 |
| 2026-10-19 | CODX | 0.00 | 9.87 | 5.78 |
| 2026-10-20 | CODX | 0.00 | 9.87 | 5.78 |
| 2026-10-21 | CODX | 0.00 | 9.87 | 5.78 |
| 2026-10-22 | CODX | 0.00 | 9.87 | 5.78 |
| 2026-10-23 | CODX | 0.00 | 9.87 | 5.78 |
| 2026-10-26 | CODX | 0.00 | 9.87 | 5.78 |
| 2026-10-27 | CODX | 0.00 | 9.87 | 9.05 |
| 2026-10-28 | CODX | 0.00 | 9.87 | 9.05 |
| 2026-10-29 | CODX | 0.00 | 9.87 | 9.05 |
| 2026-10-30 | CODX | 0.00 | 9.87 | 9.05 |
| 2026-11-02 | CODX | 0.00 | 7.50 | 7.64 |
| 2026-11-03 | CODX | 0.00 | 7.50 | 7.64 |
| 2026-11-05 | CODX | 0.00 | 7.50 | 7.64 |
| 2026-11-06 | CODX | 0.00 | 7.50 | 7.64 |
| 2026-11-09 | CODX | 0.00 | 7.63 | 0 |
| 2026-11-10 | CODX | 0.00 | 7.63 | 7.10 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
21 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-1.46
Avg. EPS Est. Current Quarter
-1.25
Avg. EPS Est. Next Quarter
-0.27
Insider Transactions
Institutional Transactions
7.63
Beta
3.21
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
27
Growth Score
34
Sentiment Score
17
Actual DrawDown %
99.9
Max Drawdown 5-Year %
-99.9
Target Price
4
P/E
Forward P/E
PEG
P/S
4.22
P/B
0.22
P/Free Cash Flow
EPS
-18.81
Average EPS Est. Cur. Y
-3.1
EPS Next Y. (Est.)
-0.83
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-7252.62
Relative Volume
92.41
Return on Equity vs Sector %
-100
Return on Equity vs Industry %
-100
EPS 1 7Days Diff
10.4
EPS 1 30Days Diff
10.4
EBIT Estimation
◆
CODX
Healthcare
$0.29
📉
N/A
Swing / Pullback
Buy the dip on strong trends
WEAK
Trend
0/20
Pullback
11/25
Volume
3/15
Valuation
12/20
TP/AR
2/10
Options
0/10
RSI
24.6
Range 1M
5.2%
Sup Dist
6.2%
🚀
N/A
Momentum Growth
Ride accelerating trends
WEAK
Momentum
0/25
Growth
29/30
Estimates
0/20
Inst/Vol
8/15
Options
0/10
EPS Yr
91.2%
EPS NY
73.2%
52W%
0.4%
💎
N/A
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+1279.3% upside
Quality
2/30
Valuation
16/30
Growth
21/25
Stability
5/10
LT Trend
1/5
Upside
+1279.3%
Quality
27
Click a card to see score breakdown
Full Analysis →
CODX — P/E HistoricalDiagnostics & Research
Sector: Healthcare
Industry: Medical Devices
Employees: 115
Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers Co-Dx PCR platform, a polymerase chain reaction testing to patients in point-of-care and at-home setting. The company also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, malaria, dengue, human papillomavirus, chikungunya, and Zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. Co-Diagnostics, Inc. was incorporated in 2013 and is based in Salt Lake City, Utah.
CODX
Latest News
—
Caricamento notizie per CODX…
stock quote shares CODX – Co-Diagnostics, Inc. Stock Price stock today
news today CODX – Co-Diagnostics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch CODX – Co-Diagnostics, Inc. yahoo finance google finance
stock history CODX – Co-Diagnostics, Inc. invest stock market
stock prices CODX premarket after hours
ticker CODX fair value insiders trading